Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Epidemiology
-
2. Epidemiology of obesity
- Prof. Jacob Seidell
- Etiology and Causes
-
3. Metabolic, adipose tissue and muscle predictors of obesity
- Prof. Ian Macdonald
-
4. Neural control of food intake and energy balance
- Prof. Hans-Rudolf Berthoud
-
6. Dietary determinants of obesity
- Prof. Arne Astrup
-
7. Physical inactivity as a determinant of obesity
- Prof. Wim Saris
-
8. Environmental causes of obesity: sociocultural, built environment and economic factors
- Prof. Shiriki Kumanyika
-
9. The developmental origins of obesity
- Prof. David Barker
- Consequences of Obesity
-
10. Obesity, dyslipoproteinemia and inflammation
- Prof. Robert Eckel
-
11. Pathophysiology and management of obesity related hypertension
- Prof. Arya Sharma
-
12. Disorders of overeating
- Prof. Albert Stunkard
-
13. Obesity, weight loss and health-related quality of life
- Prof. Aila Rissanen
- Dr. Jarmo Kaukua
- Treatment Options
-
14. Lifestyle modification for weight control
- Prof. Thomas Wadden
-
15. Bariatric / obesity surgery
- Prof. Henry Buchwald
-
16. Can obesity be prevented in the current obesogenic environment?
- Prof. Boyd Swinburn
-
17. Pharmacotherapy for obesity: why it is needed
- Prof. Joe Proietto
-
18. Pharmacotherapy for obesity: hunger suppressors
- Prof. Joe Proietto
- Latest Developments in the Field
-
19. Body composition
- Dr. Steven Heymsfield
-
20. Adipose tissue metabolism and obesity
- Dr. Max Lafontan
-
21. Obesity, present and future therapies
- Prof. Sir Stephen Bloom
-
22. Energy expenditure in the lean and obese
- Prof. Dale Schoeller
-
23. Obesity and adiponectin
- Prof. Philipp Scherer
-
24. Ectopic fat: causes, consequences and treatment
- Prof. Steven Smith
-
25. Adipose-immune interactions in obesity
- Dr. Vishwa Dixit
-
26. Health benefits of intentional weight loss
- Prof. Xavier Pi-Sunyer
-
27. Childhood obesity: implications for current and future health
- Prof. Peter T. Katzmarzyk
- Archived Lectures - These lectures may not cover the latest advances in the field
-
29. Gastrointestinal peptides and food intake regulation
- Prof. Sir Stephen Bloom
-
30. Obesity and mortality: questions and controversy
- Prof. David Allison
-
31. Obesity, diabetes and the cluster of the metabolic syndrome
- Prof. Peter Wilson
-
33. Health economics of obesity: new insights
- Dr. Anne Wolf
-
34. Bariatric surgery: techniques and mechanisms of action
- Prof. Walter Pories
-
35. Childhood obesity: implications for future health
- Prof. Peter T. Katzmarzyk
Printable Handouts
Navigable Slide Index
- Introduction
- Diabetes and CVD risk in Framingham cohort
- Population attributable risk percent effects - men
- Population attributable risk percent effects - women
- Natural history of type 2 diabetes
- Typical levels of insulin sensitivity
- Assessment of insulin resistance
- Increased CVD risk factors precede type 2 DM
- Insulin resistance and atherosclerosis
- Syndrome X
- Metabolic traits cluster with hyperinsulinemia
- Risk variables for a metabolic syndrome
- Shared risk variables
- CHD mortality and hyperinsulinemia
- Diabetes and lipid extremes - men
- Diabetes and lipid extremes - women
- Adiposity and vascular inflammation
- ATP III: the metabolic syndrome
- ATP III: the metabolic syndrome since 2001
- WHO: the metabolic syndrome
- IDF: the metabolic syndrome
- Age specific prevalence
- Age-adjusted prevalence by race/ethnicity
- Prevalence of the metabolic syndrome
- Prevalence of coronary artery calcification (1)
- Prevalence of coronary artery calcification (2)
- Left ventricular mass according to insulin resistance
- Mean CRP levels and the number of components
- Metabolic syndrome risk factor sum - men
- Metabolic syndrome risk factor sum - women
- Metabolic syndrome outcomes - men
- Metabolic syndrome outcomes - women
- Metabolic syndrome factors age adjusted risk
- Metabolic syndrome clustering
- Prevalence of metabolic syndrome clustering
- Metabolic syndrome clustering and relative risk
- Age-adjusted hazard ratios for MI
- Age and sex-adjusted hazard ratios
- Risk for CHD events and new onset diabetes
- Development of T2DM and CVD
- Summary
Topics Covered
- The effect of diabetes, obesity and overweight on risks for heart disease
- Framingham Heart Study analyses
- The effects in men and women
- Metabolic studies of new diabetes
- Population studies
- Metabolic risk factor abnormalities generally precede the development of type 2 diabetes mellitus and contribute to the development of diabetes mellitus and accelerated atherosclerosis
- Differences in lipids and triglycerides
- Prevalence of the syndrome rises with age: increased risk of diabetes mellitus, subclinical vascular disease and clinical cardiovascular disease
- Risk for the development of vascular disease
- The European DECODE study
- The AFCAPS study
- Presence of the metabolic syndrome and increased levels of the inflammatory marker CRP may help to identify persons at higher risk of type 2 diabetes or vascular disease
Talk Citation
Wilson, P. (2007, October 1). Obesity, diabetes and the cluster of the metabolic syndrome [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 20, 2025, from https://doi.org/10.69645/FWJG2528.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Peter Wilson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.